Emerging treatment options for advanced esophageal squamous cell carcinoma: an interview with Ken Kato

Please introduce yourself, your research background and current research interests. My name is Ken Kato and I am a gastrointestinal oncologist at the National Cancer Center Hospital (Tokyo, Japan). My special interest is esophageal cancer, especially squamous cell carcinoma and gastric cancer, but I have conducted many clinical trials for esophageal cancer. For example, the Phase II trial of chemoradiotherapy for esophageal squamous cell carcinoma (ESCC). I am the group coordinator of the Japan Clinical Oncology Group esophageal cancer study group and I am the Principle Investigator for the Phase III trial of the comparison of neoadjuvant chemotherapy and adjuvant...